Learn how tumor marker tests can help doctors diagnose cancer and plan the best possible treatment plan for each person.
Cancer.Net Associate Editors explain research presented at the 2019 ASCO Annual Meeting, including new research in colon cancer, gastric cancer, pancreatic cancer, and leukemia.
ASCO Annual Meeting 2019: Immunotherapy for Lung Cancer, Gastrointestinal Cancers and Targeted Therapy for Breast Cancer
The ASCO Annual Meeting is where many new cancer research findings are announced. Today’s key research highlights include treatment advances for advanced lung cancer, stomach cancer, gastroesophageal junction cancer, and breast cancer.
Can immunotherapy be used to treat breast cancer? This expert Q&A explains.
Treating Advanced Prostate Cancer and Kidney Cancer: Research from the 2019 Genitourinary Cancers Symposium
The 2019 Genitourinary Cancers Symposium will feature new research on treatments for prostate cancer and kidney cancer.
In this podcast, Cancer.Net Associate Editor Dr. Michael Williams describes lymphoma research advances presented at the American Society of Hematology Annual Meeting.
Some recent FDA approvals have made many people aware of tumor-agnostic treatments. But what does that mean and how could it benefit someone with cancer? ASCO Chief Medical Officer Richard L. Schilsky gives insight into this new way of thinking about cancer treatment.
Cancer-Related Pain and Immunotherapy Side Effects: Research from the 2018 Palliative and Supportive Care in Oncology Symposium
Research highlights from the 2018 Palliative and Supportive Care in Oncology Symposium include an AI-based app that helps reduce the burden of cancer-related pain and an awareness that immunotherapy may cause more side effects than originally thought.
Kidney cancer is the sixth most common cancer for men and the tenth most common cancer for women. Cancer.Net Associate Editor Brian Rini, MD, shares 4 things people need to know about kidney cancer.